Effects of long-term lamivudine therapy in renal-transplant patients.
暂无分享,去创建一个
L. Rostaing | J. Izopet | N. Kamar | D. Durand | D. Ribes | M. Duffaut | J. Selves | K. Sandres-Sauné
[1] M. Wulfsohn,et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. , 2003, The New England journal of medicine.
[2] M. Wulfsohn,et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. , 2003, The New England journal of medicine.
[3] O. Musa. CONTROL OF HEPATITIS B INFECTION , 2003 .
[4] T. Chan,et al. Preemptive lamivudine therapy based on HBV DNA level in HBsAg‐positive kidney allograft recipients , 2002, Hepatology.
[5] C. Mandl,et al. Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. , 2000, The Journal of infectious diseases.
[6] Nicholson,et al. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L‐FMAU, DAPD, penciclovir and lobucavir , 2000, Journal of viral hepatitis.
[7] D. Pillay,et al. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. , 1999, Journal of hepatology.
[8] P Coriat,et al. Impact of hepatitis B and C virus on kidney transplantation outcome , 1999, Hepatology.
[9] D. Pillay,et al. Analysis of Hepatitis B Virus Quasispecies Changes during Emergence and Reversion of Lamivudine Resistance in Liver Transplantation , 1999, Antiviral therapy.
[10] C. Gibbs,et al. Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro , 1998, Hepatology.
[11] W. Yang,et al. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. , 1998, Transplantation.
[12] N. Leung,et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 1998, The New England journal of medicine.
[13] A. Bartholomeusz,et al. Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease , 1998 .
[14] L. Rostaing,et al. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. , 1997, Transplantation.
[15] Chiu-Ching Huang,et al. Hepatitis in patients with end‐stage renal disease , 1997, Journal of gastroenterology and hepatology.
[16] P. Chossegros,et al. Treatment of hepatitis B virus replication by ganciclovir in kidney transplant patients. , 1997, Transplantation proceedings.
[17] A. Burroughs,et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis , 1996, The Lancet.
[18] H. Schaller,et al. Hepatitis B virus replication‐an update , 1996, Journal of viral hepatitis.
[19] F. Carnot,et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. , 1996, Transplantation.
[20] M. Manns,et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[21] L. Rostaing,et al. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. , 1996, Nephron.
[22] E. Schiff,et al. A preliminary trial of lamivudine for chronic hepatitis B infection. , 1995, The New England journal of medicine.
[23] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[24] A. Couroucé,et al. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. , 1994, Virology.
[25] A. Detsky,et al. Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1993, Annals of Internal Medicine.
[26] S. Kwok,et al. Avoiding false positives with PCR , 1989, Nature.
[27] N. Saitou,et al. The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.
[28] M. Lavenhar,et al. Control of hepatitis B infection. The role of surveillance and an isolation hemodialysis center. , 1981, JAMA.